A pilot of MELODIC was conducted on two CPFT dementia wards, embedding a music therapist to deliver clinical sessions and personalised care plans.

Tejal Somvanshi

Slight rises in agitation were recorded alongside small gains in quality‑of‑life and reduced distress and disruptiveness among patients.

Photo Source: Cottonbro studio (Pexels)

No adverse events or increases in routine incidents were reported during the study period.

Photo Credit: Geralt (Pixabay)

Interviews with 49 staff, patients and families shaped the intervention and were published in the International Journal of Geriatric Psychiatry.

Photo Credit: Tima Miroshnichenko (Pexels)

Costs were kept low at £2,025 per month for the therapist and a one‑time £400 equipment investment.

Photo Credit: Geralt (Pixabay)

Findings were published in Frontiers in Psychiatry in July 2025, highlighting feasibility in complex mental health settings.

Photo Source: Barbara Olsen(Pexels)

Neurological pathways were examined in a December 2024 realist review in Nature Mental Health, showing limbic activation and neuroplastic benefits.

Photo Source: Barbara Olsen (Pexels)

The MELODIC study was built on the HOMESIDE trial and ARU’s 2021 Queen’s Anniversary Prize research, reinforcing non‑drug dementia care.

Photo Source: Free Range STock (CC0)